Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PDI and Polymedco CDP Jointly Announce US Commercial Licensing Agreement

Published: Tuesday, July 03, 2012
Last Updated: Tuesday, July 03, 2012
Bookmark and Share
Polymedco to commercialize PDI’s diagnostic blood test that assesses an individual’s risk of CRC.

Phenomenome Discoveries Inc. and Polymedco Cancer Diagnostic Products LLC. have announced a commercial licensing agreement for the US market, providing rights to Polymedco to commercialize PDI’s diagnostic blood test that assesses an individual’s risk of colorectal cancer (“CRC”).

Using patented technology, PDI has discovered that approximately nine out of ten patients with CRC are deficient in novel anti-cancer and anti-inflammatory metabolites in their blood.

PDI has developed a convenient blood test assayed by triple quad mass spectrometry that can detect this deficiency.

PDI’s blood test is a simple non-invasive means of identifying individuals with increased risk of CRC. This blood test is expected to significantly improve CRC screening compliance.

On May 18, 2012 PDI presented results from a landmark multi-site, six thousand subject clinical trial evaluating the performance of the CRC test at the Digestive Disease Week (DDW) meeting in San Diego in which the blood test was found to detect over 85% of early stage CRC.

DDW is the largest and most prestigious meeting in the world for GI professionals. Every year it attracts approximately 16,000 physicians, researchers and academics from around the world.

“We are extremely pleased to be working with Polymedco to commercialize this test in the US market,” said John Hyshka, PDI’s Chief Financial and Operating Officer, “PDI has a number of similar products that are nearing market launch, and Polymedco’s unparalleled expertise as a world-leader in marketing and distributing non-invasive colorectal cancer screening products is very valuable.”

Dr. Dayan Goodenowe, PDI’s President and CEO, says “Polymedco’s proficiency has enabled us to exceed our goals and timelines around making this test available in the US. A month ago, we jointly submitted an application for FDA premarket review, and we look forward to receiving approval and moving ahead with our shared commercialization strategy.”

“We are excited about this new alliance with Phenomenome Discoveries. This new non-invasive technology adds to our cancer testing portfolio of market leading tests. We believe that this test will facilitate the screening of more patients annually for colorectal cancer. Increased screening rates will detect more cancers at an earlier stage, resulting in more lives saved,” said Drew Cervasio, President of Polymedco Cancer Diagnostic Products.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Promising Class of New Cancer Drugs Cause Memory Loss in Mice
New findings from The Rockefeller University suggest that the original version of BET inhibitors causes molecular changes in mouse neurons, and can lead to memory loss in mice that receive it.
Electrical Control of Cancer Cells
Research led by scientists at The University of Texas Health Science Center at Houston (UTHealth) has revealed a new electrical mechanism that can control these switches.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Inflammation Linked to Colon Cancer Metastasis
A new Arizona State University research study led by Biodesign Institute executive director Raymond DuBois has identified for the first time the details of how inflammation triggers colon cancer cells to spread to other organs, or metastasize.
Structural Discoveries Could Aid in Better Drug Design
Scientists have uncovered the structural details of how some proteins interact to turn two different signals into a single integrated output.
Determining the Age of Fingerprints
Watch the imprint of a tire track in soft mud, and it will slowly blur, the ridges of the pattern gradually flowing into the valleys. Researchers have tested the theory that a similar effect could be used to give forensic scientists a way to date fingerprints.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!